Our findings that CD147 is a candidate surface marker of cancer cell‐derived EVs and that miRNAs are enriched in CD147+ EVs raise the possibility that CD147 immunocapture could increase detection of cancer‐derived circulating miRNAs. The gene discussed is BSG; the disease is cancer.